Q1 2019 Hansa Biopharma AB Earnings Call Transcript
Ladies and gentlemen, welcome to the Hansa Biopharma Teleconference Q1 2019 Call. Today, I'm pleased to present Søren Tulstrup, President and CEO. (Operator Instructions) Søren, please begin your meeting.
¸ -
Thank you, operator. Hello, I'm Søren Tulstrup, President and CEO of Hansa Biopharma. Welcome to Hansa Biopharma's conference call on the results for the first quarter of 2019.
Please turn to Slide 2. Please allow me to draw your attention to the forward-looking statements, which apply to this presentation.
Please turn to Slide 3. I'm joined here today by Eva-Maria Joed, Vice President and Chief Financial Officer. As previously communicated, Donato Spota will be starting as our new Chief Financial Officer in May, so he will be taking over from Eva-Maria at our next quarterly results call. Eva-Maria will be working closely with Donato in her new role as Vice President of Finance and Administration.
Also, I'm pleased to welcome Klaus Sindahl as our new Head
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |